Zhengye Biotechnology Holding (ZYBT) Income Statement

Zhengye Biotechnology Holding reported revenue of CNY 116.36M in fiscal 2025 (fiscal year ended Dec 31, 2025), down 37.6% from CNY 186.36M a year earlier. Zhengye Biotechnology Holding posted a net loss of CNY 69.78M, compared with net income of CNY 11.31M a year earlier. Gross margin was 20.5% and operating margin -58.7%.

Zhengye Biotechnology Holding Income Statement Analysis

Values in millions CNY

Income Statement Balance Sheet Cash Flow Ratios

Scale:

Scroll to see more

Zhengye Biotechnology Holding Limited income statement - Annual data in millions CNY
Breakdown	FY 2025	FY 2024	FY 2024	FY 2023	FY 2022	FY 2021
Period ending	Dec 2025	Jun 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021
Revenue & Gross Profit
Revenue	116.36	186.36	186.36	211.65	260.27	214.07
Cost of Revenue	92.49	95.06	95.06	94.14	112.39	89.45
Gross Profit	23.87	91.30	91.30	117.51	147.88	125.39
Operating Expenses
Research & Development	18.01	12.79	12.79	11.90	13.42	11.37
Selling, General & Administrative	74.92	63.84	63.84	64.34	58.89	58.86
Operating Expenses	92.12	74.86	74.86	69.87	82.05	73.01
Operating Income	-68.25	16.44	16.44	47.64	65.83	52.38
Other Income/Expense
Interest Income	0.10	0.23	0.23	0.31	0.11	0.11
Interest Expense	3.40	4.04	-4.04	4.42	-2.84	-1.05
Other Income/Expense	-0.32	-2.05	-2.05	0.23	-1.92	0.68
Income
Income Before Tax	-71.87	14.39	14.39	43.76	63.91	53.07
Income Tax Expense	11.10	0.92	0.92	6.25	8.17	6.60
Net Income	-69.78	11.31	11.31	31.46	46.74	46.47
Net Income - Continuous Operations	-82.97	11.31	13.47	37.51	46.74	46.47
Net Income - Discontinued Operations	-	-	-	-	-	-
EBITDA	-42.52	42.60	40.60	72.10	84.63	68.48
EBIT	-68.47	-	16.44	48.19	65.83	52.47
Depreciation & Amortization	25.96	24.16	24.16	23.91	18.80	16.01
Earnings Per Share
Basic EPS	-1.00	-	-	1.00	1.00	1.00
Diluted EPS	-1.00	-	-	1.00	1.00	1.00
Basic Shares Outstanding	47.35	47.17	45.67	45.67	45.67	45.67
Diluted Shares Outstanding	47.35	47.17	45.67	47.17	45.67	45.67

Source: Company financial statements from annual and quarterly filings. Data as of Dec 31, 2025. Data sources and methodology

Frequently Asked Questions About Zhengye Biotechnology Holding Financial Statements

What was Zhengye Biotechnology Holding's revenue in fiscal 2025?

Zhengye Biotechnology Holding reported revenue of CNY 116.36M in fiscal 2025 (fiscal year ended Dec 31, 2025). That was down 37.6% from CNY 186.36M a year earlier.

Is Zhengye Biotechnology Holding profitable?

No. Zhengye Biotechnology Holding reported a net loss of CNY 69.78M in fiscal 2025. In fiscal 2024 it earned CNY 11.31M.

What is Zhengye Biotechnology Holding's operating margin?

Zhengye Biotechnology Holding's operating income was −CNY 68.25M on revenue of CNY 116.36M in fiscal 2025, an operating margin of -58.7%, compared with 8.8% a year earlier.

What is net profit margin?

Net profit margin is net income divided by revenue. It shows how much of each dollar of sales a company keeps as profit after all costs, interest and taxes. Full definition